Cipla had one of its worst quarters. Investors still rewarded it
· the-ken.com
Cipla has had one of its worst quarterly profit drops in Q4 FY26. Yet, the day after it announced the results, its stock ran up 8%
Cipla has sold inhalers for decades. So its announcement of another such product shouldn’t move the market. Yet, it did.
On 14 May, the day after the company...